Insulet Corporation
PODD · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $2.71B | $2.07B | +30.7% |
| Operating income | $474M | $309M | +53.4% |
| Net income | $247M | $418M | −40.9% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $842M | $706M | +19.2% |
| Operating income | $190M | $118M | +61.3% |
| Net income | $141M | $87.6M | +61.1% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Insulet's revenue in FY2025?
- $2.71B in FY2025 (Fiscal year ended Dec 31, 2025), +30.7% vs $2.07B a year earlier, per its 10-K filed Feb 2026.
- Was Insulet profitable in FY2025?
- Yes: net income was $247M and operating income $474M in FY2025.
- What was Insulet's revenue in Q3 2026?
- $842M (+19.2% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.